In a new study, scientists discovered two cancer drugs that could also be effective at combatting one well-known symptom of ...

Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say.

Researchers at Northwestern University published in ACS Nano have redesigned a common chemotherapy drug using nanotechnology, ...

The CNPV has an expedited review process of 1 to 2 months. According to the FDA, the "cornerstone" of the process is a 1-day ...

One of the key findings was that proton pump inhibitors (PPIs), which are often used to treat acid reflux and heartburn, were ...

A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies. Published in the journal Molecular Cancer, the ...

The moment she heard that her mother, then 67, had advanced breast cancer, Stacie Dusetzina began hunting for potential treatments. A cancer policy researcher at Vanderbilt University, Dusetzina knew ...

Pfizer PFE is one of the largest and most successful drugmakers in oncology. It boasts a strong portfolio of approved cancer medicines as well as a robust pipeline of cancer candidates with a focus on ...

Over half a million bottles of prazosin hydrochloride have been recalled for having high levels of potentially cancer-causing ...